MAPK3 and neoplasm: demonstrated that SULF2 promotes proliferation and metastasis of colorectal cancer by activating the Akt and Erk1/2 signalling pathways; its high expression is associated with malignant clinical features and poor prognosis, and knockdown of SULF2 significantly suppresses tumour growth and invasion.